ZLD 2.86% 72.0¢ zelira therapeutics limited

mm reasearch epilepsy, page-3

  1. 1,275 Posts.
    lightbulb Created with Sketch. 145
    https://www.leafly.com/news/industr...ctoria?utm_source=dlvr.it&utm_medium=facebook

    Cann10 says it has recruited prominent figures from the cannabis industry in Australia and around the world to deliver lectures. Speakers include Peter Crock, the CEO of Australian Cann Group Ltd, which was the first company to be granted a commercial cultivation licence for medical cannabis; Phil Warner, managing director of Ecofibre; director of Zelda Therapeutics Mara Gordon, as well as a number of respected academics and researchers.
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.